SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer

  • Authors:
    • Kazuya Shinmura
    • Hisami Kato
    • Yuichi Kawanishi
    • Kiyoko Nagura
    • Takaharu Kamo
    • Yusuke Okubo
    • Yusuke Inoue
    • Nobuya Kurabe
    • Chunping Du
    • Moriya Iwaizumi
    • Kiyotaka Kurachi
    • Toshio Nakamura
    • Haruhiko Sugimura
  • View Affiliations

  • Published online on: May 28, 2015     https://doi.org/10.3892/or.2015.4014
  • Pages: 727-738
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Spindle assembly abnormal protein 6 homolog (SASS6) plays an important role in the regulation of centriole duplication. To date, the genetic alteration of SASS6 has not been reported in human cancers. In the present study, we examined whether SASS6 expression is abnormally regulated in colorectal cancers (CRCs). Increased SASS6 mRNA and protein expression levels were observed in 49 (60.5%) of the 81 primary CRCs and 11 (57.9%) of the 19 primary CRCs, respectively. Moreover, the upregulation of SASS6 mRNA expression was statistically significant (P=0.0410). Next, using DLD-1 colon cancer cells inducibly expressing SASS6, SASS6 overexpression was shown to induce centrosome amplification, mitotic abnormalities such as chromosomal misalignment and lagging chromosome, and chromosomal numerical changes. Furthermore, SASS6 overexpression was associated with anaphase bridge formation, a type of mitotic structural abnormality, in primary CRCs (P<0.01). SASS6 upregulation in colon cancer was also revealed in the Cancer Genome Atlas (TCGA) data and was shown to be an independent predictor of poor survival (multivariate analysis: hazard ratio, 2.805; 95% confidence interval, 1.244‑7.512; P=0.0112). Finally, further analysis of the TCGA data demonstrated SASS6 upregulation in a modest manner in 8 of 11 cancer types other than colon cancer, and SASS6 upregulation was found to be associated with a poor survival outcome in patients with kidney renal cell carcinoma and lung adenocarcinoma. Our present findings revealed that the upregulation of SASS6 expression is involved in the pathogenesis of CRC and is associated with a poor prognosis among patients with colon cancer. They also suggest that SASS6 upregulation is a genetic abnormality relatively common in human cancer.
View Figures
View References

Related Articles

Journal Cover

August-2015
Volume 34 Issue 2

Print ISSN: 1021-335X
Online ISSN:1791-2431

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Shinmura K, Kato H, Kawanishi Y, Nagura K, Kamo T, Okubo Y, Inoue Y, Kurabe N, Du C, Iwaizumi M, Iwaizumi M, et al: SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer. Oncol Rep 34: 727-738, 2015
APA
Shinmura, K., Kato, H., Kawanishi, Y., Nagura, K., Kamo, T., Okubo, Y. ... Sugimura, H. (2015). SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer. Oncology Reports, 34, 727-738. https://doi.org/10.3892/or.2015.4014
MLA
Shinmura, K., Kato, H., Kawanishi, Y., Nagura, K., Kamo, T., Okubo, Y., Inoue, Y., Kurabe, N., Du, C., Iwaizumi, M., Kurachi, K., Nakamura, T., Sugimura, H."SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer". Oncology Reports 34.2 (2015): 727-738.
Chicago
Shinmura, K., Kato, H., Kawanishi, Y., Nagura, K., Kamo, T., Okubo, Y., Inoue, Y., Kurabe, N., Du, C., Iwaizumi, M., Kurachi, K., Nakamura, T., Sugimura, H."SASS6 overexpression is associated with mitotic chromosomal abnormalities and a poor prognosis in patients with colorectal cancer". Oncology Reports 34, no. 2 (2015): 727-738. https://doi.org/10.3892/or.2015.4014